鲁抗医药
(600789)
| 流通市值：88.43亿 | | | 总市值：88.43亿 |
| 流通股本：8.99亿 | | | 总股本：8.99亿 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 716,996,053 | 703,936,711.12 | 772,536,945.22 | 908,214,646.54 |
| 交易性金融资产 | 0 | - | 1,220,160 | 1,237,380 |
| 应收票据及应收账款 | 1,103,764,942.54 | 1,223,580,194.14 | 940,440,122.12 | 873,993,894.97 |
| 应收账款 | 1,103,764,942.54 | 1,223,580,194.14 | 940,440,122.12 | 873,993,894.97 |
| 应收款项融资 | 444,234,258.86 | 405,745,917.21 | 496,587,244.23 | 646,380,420.76 |
| 预付款项 | 37,416,314.2 | 78,107,145.27 | 49,730,071.3 | 77,235,467.53 |
| 其他应收款合计 | 325,893,734.32 | 375,206,468 | 354,780,622.27 | 352,564,754.11 |
| 存货 | 1,258,666,581.05 | 1,359,188,675.35 | 1,484,208,209.11 | 1,317,991,495.87 |
| 其他流动资产 | 29,662,263.42 | 23,571,726.28 | 30,798,429.37 | 25,721,856.34 |
| 流动资产合计 | 3,916,634,147.39 | 4,169,336,837.37 | 4,130,301,803.62 | 4,203,339,916.12 |
| 非流动资产: | | | | |
| 长期应收款 | - | - | - | 0 |
| 长期股权投资 | 68,021,555.28 | 68,888,897.26 | 70,196,407.68 | 71,956,782.02 |
| 其他权益工具投资 | 16,417,126.21 | 16,498,146.82 | 17,804,315.99 | 22,825,209.27 |
| 投资性房地产 | 45,876,364.42 | 40,874,618 | 41,542,566.32 | 52,112,743.21 |
| 固定资产 | 3,578,008,406.03 | 3,655,241,733.02 | 3,710,666,844.9 | 3,652,318,882.14 |
| 在建工程 | 242,311,975.29 | 169,169,811.07 | 121,858,867.39 | 177,758,224.47 |
| 无形资产 | 784,077,942.74 | 760,544,098.51 | 766,203,266.06 | 722,830,758.69 |
| 开发支出 | 149,719,682.34 | 145,874,093.87 | 127,280,307.33 | 135,359,658.16 |
| 长期待摊费用 | 1,051,811.41 | 1,246,598.7 | 1,121,634.11 | 632,880.61 |
| 递延所得税资产 | 22,712,590.24 | 23,597,869.12 | 24,026,545.78 | 30,656,966.4 |
| 其他非流动资产 | 62,531,387.87 | 84,634,275.97 | 86,982,317.24 | 80,246,974.06 |
| 非流动资产合计 | 4,970,728,841.83 | 4,966,570,142.34 | 4,967,683,072.8 | 4,946,699,079.03 |
| 资产总计 | 8,887,362,989.22 | 9,135,906,979.71 | 9,097,984,876.42 | 9,150,038,995.15 |
| 流动负债: | | | | |
| 短期借款 | 915,130,842.18 | 964,145,432.39 | 871,771,193.79 | 759,339,913.32 |
| 应付票据及应付账款 | 1,268,976,331.86 | 1,442,414,231.06 | 1,502,685,721.71 | 1,689,977,067.28 |
| 其中：应付票据 | 480,872,944.89 | 613,316,819.17 | 602,428,121.69 | 838,948,931.28 |
| 应付账款 | 788,103,386.97 | 829,097,411.89 | 900,257,600.02 | 851,028,136 |
| 预收款项 | - | - | - | 0 |
| 合同负债 | 61,075,946.2 | 88,081,728.16 | 104,655,572.38 | 89,572,030.89 |
| 应付职工薪酬 | 17,692,754.97 | 14,254,372.67 | 16,442,255.84 | 22,405,799.28 |
| 应交税费 | 28,010,632.38 | 31,726,391.56 | 21,829,493.16 | 24,661,700.5 |
| 其他应付款合计 | 222,696,298.46 | 263,095,344.83 | 250,539,831.37 | 204,427,930.8 |
| 应付股利 | 1,680,905.49 | 1,680,905.49 | 1,680,905.49 | 1,680,905.49 |
| 一年内到期的非流动负债 | 626,018,435.69 | 446,363,890.63 | 282,557,078.4 | 678,968,254.37 |
| 其他流动负债 | 6,110,523.61 | 9,498,234.47 | 10,450,921.97 | 21,107,081.63 |
| 流动负债合计 | 3,145,711,765.35 | 3,259,579,625.77 | 3,060,932,068.62 | 3,490,459,778.07 |
| 非流动负债: | | | | |
| 长期借款 | 1,363,960,000 | 1,447,860,000 | 1,685,900,000 | 1,362,826,000 |
| 长期应付款 | 123,857,705 | 123,857,705 | 123,857,705 | 123,857,705 |
| 递延收益 | 162,484,304.36 | 161,896,194.56 | 165,724,728.06 | 139,911,883.43 |
| 非流动负债合计 | 1,650,302,009.36 | 1,733,613,899.56 | 1,975,482,433.06 | 1,626,595,588.43 |
| 负债合计 | 4,796,013,774.71 | 4,993,193,525.33 | 5,036,414,501.68 | 5,117,055,366.5 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 898,669,632 | 898,669,632 | 898,669,632 | 898,669,632 |
| 资本公积 | 1,698,137,293.88 | 1,698,137,293.88 | 1,698,137,293.88 | 1,698,137,293.88 |
| 其他综合收益 | -23,582,873.79 | -23,501,853.18 | -22,195,684.01 | -17,174,790.73 |
| 专项储备 | 1,488,399.77 | 1,240,288.77 | 1,140,010.53 | 987,284.94 |
| 盈余公积 | 207,388,115.67 | 207,388,115.67 | 207,388,115.67 | 178,378,793.5 |
| 未分配利润 | 1,162,050,245.62 | 1,213,643,496.17 | 1,135,045,846.28 | 1,134,471,263.96 |
| 归属于母公司股东权益合计 | 3,944,150,813.15 | 3,995,576,973.31 | 3,918,185,214.35 | 3,893,469,477.55 |
| 少数股东权益 | 147,198,401.36 | 147,136,481.07 | 143,385,160.39 | 139,514,151.1 |
| 股东权益合计 | 4,091,349,214.51 | 4,142,713,454.38 | 4,061,570,374.74 | 4,032,983,628.65 |
| 负债和股东权益合计 | 8,887,362,989.22 | 9,135,906,979.71 | 9,097,984,876.42 | 9,150,038,995.15 |
| 公告日期 | 2025-08-28 | 2025-04-30 | 2025-03-22 | 2024-10-30 |
| 审计意见(境内) | | | 标准无保留意见 | |